Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Novo Nordisk Limited
Broadfield Park, Brighton Road, Crawley, West Sussex, RH11 9RT
Telephone: +44 (0)1293 613555
Fax: +44 (0)1293 613535
Medical Information Direct Line: +44 (0)845 600 5055
Medical Information e-mail: ukmedicalinfo@novonordisk.com
Customer Care direct line: +44 (0)845 600 5055
Medical Information Fax: +44 (0)1293 613211

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 10/05/2012
PIL NovoMix 30 Penfill 100 U/ml, suspension for injection in cartridge.

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/05/2012 and displayed until Current
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 14/09/2011 and displayed until 10/05/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 24/09/2010 and displayed until 14/09/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to storage instructions
  • Change to side-effects
  • Change to information about drinking alcohol
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to dosage and administration
Updated on 06/04/2010 and displayed until 24/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
  • Change to drug interactions
Updated on 17/02/2010 and displayed until 06/04/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to how the medicine works
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
Updated on 02/06/2008 and displayed until 17/02/2010
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 24/08/2007 and displayed until 02/06/2008
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
Updated on 07/03/2007 and displayed until 24/08/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 15/02/2007 and displayed until 07/03/2007
Reasons for adding or updating:
  • Change of manufacturer
Updated on 12/12/2006 and displayed until 15/02/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about missed dose
  • Change to instructions about overdose
  • Change to storage instructions
  • Change to side-effects
  • Change to information about drinking alcohol
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to date of revision
  • Change to how to administer the medicine
Updated on 28/03/2002 and displayed until 12/12/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  insulin aspart